This collection highlights a selection of the best articles published in 2021 from the Cardiovascular Therapeutics section of Frontiers in Cardiovascular Medicine.
The specialty section Cardiovascular Therapeutics aims to advance the pharmacological treatment of cardiovascular disease. The section is concerned will all aspects of drug discovery and development, improving our understanding of how and why drugs work, and tailoring medicines to individuals.
Frontiers in Cardiovascular Medicine publishes peer-reviewed research articles across basic, translational, and clinical cardiovascular medicine. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal provides a unique forum that helps scientists and clinicians to disseminate novel discoveries and technologies widely, advance scientific knowledge rapidly, and propose new paradigms and theories.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.
This collection highlights a selection of the best articles published in 2021 from the Cardiovascular Therapeutics section of Frontiers in Cardiovascular Medicine.
The specialty section Cardiovascular Therapeutics aims to advance the pharmacological treatment of cardiovascular disease. The section is concerned will all aspects of drug discovery and development, improving our understanding of how and why drugs work, and tailoring medicines to individuals.
Frontiers in Cardiovascular Medicine publishes peer-reviewed research articles across basic, translational, and clinical cardiovascular medicine. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal provides a unique forum that helps scientists and clinicians to disseminate novel discoveries and technologies widely, advance scientific knowledge rapidly, and propose new paradigms and theories.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.